MedWatch

Christian Grøndahl becomes CEO

A British pharmaceutical company has hired Christian Grøndahl as its new CEO, after he left his position as CSO in Zealand Pharma in March.

The pharmaceutical company, Kymab, has appointed the former Chief Scientific Officer in Zealand Pharma, Christian Grøndahl, as its new CEO.

Under the leadership of Christian Grøndahl the company plans to further develop its platform and advance several drug candidates to clinical development stage over the next five years.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier